• Mon. Oct 16th, 2023

St. Louis County Male Found Guilty by a Federal Jury of Trafficking a Lethal Dose of Heroin and Fentanyl

Avatar photo

ByDavid Brown

Jun 29, 2023
Wyland Kinney, 43, of St. Louis County, proved guilty by the jury of four felonies: distributing a controlled drug that caused death, distributing fentanyl twice, and possessing a pistol while a felon. In his closing remarks on Thursday, Assistant U.S. Attorney Kyle Bateman said that a string of texts and phone conversations from the victim to Kinney on August 15 and 16 of 2018 showed that the victim had made arrangements to purchase opiates from Kinney. On August 16, 2018, at 2:30 pm, Kinney offered the victim heroin and fentanyl for sale. The deceased, who was a resident of his grandmother's home, was discovered dead at around 8 p.m, 30 minutes after she had last spoken to him. The Cause of Death According to an autopsy and toxicology findings, the amount of heroin and fentanyl that combined to kill him was sufficient, according to Bateman. They swiftly murdered him together. The victim had recently left the hospital after struggling with heroin addiction. Officers got Kinney's identity and learnt about the victim's conversations and messages to him during the ensuing investigation. They then had a confidential informant make two purchases from Kinney on October 11 and 12 of a fentanyl and ketamine mixture. The Investigation Two handguns, a shotgun, ammo, and $6,443 in cash were discovered during a court-authorized search of Kinney's residence. On the main floor, a gun safe contained four pistols, four shotguns, two rifles, an AK-style pistol, and additional ammunition. On his phone, they also discovered texts relating to the selling of drugs. At the sentencing, Kinney may receive a life sentence for the distribution of a controlled substance that caused death, up to 20 years for the other drug offenses, and up to 10 years for the firearms offense. The Drug Enforcement Administration and the Florissant Police Department are still looking into this situation.
David Brown

Wyland Kinney, 43, of St. Louis County, proved guilty by the jury of four felonies: distributing a controlled drug that caused death, distributing fentanyl twice, and possessing a pistol while a felon.

In his closing remarks on Thursday, Assistant U.S. Attorney Kyle Bateman said that a string of texts and phone conversations from the victim to Kinney on August 15 and 16 of 2018 showed that the victim had made arrangements to purchase opiates from Kinney. 

On August 16, 2018, at 2:30 pm, Kinney offered the victim heroin and fentanyl for sale. The deceased, who was a resident of his grandmother’s home, was discovered dead at around 8 p.m, 30 minutes after she had last spoken to him. 

The Cause of Death

According to an autopsy and toxicology findings, the amount of heroin and fentanyl that combined to kill him was sufficient, according to Bateman. They swiftly murdered him together. The victim had recently left the hospital after struggling with heroin addiction.

Officers got Kinney’s identity and learnt about the victim’s conversations and messages to him during the ensuing investigation. They then had a confidential informant make two purchases from Kinney on October 11 and 12 of a fentanyl and ketamine mixture.

The Investigation

Two handguns, a shotgun, ammo, and $6,443 in cash were discovered during a court-authorized search of Kinney’s residence. On the main floor, a gun safe contained four pistols, four shotguns, two rifles, an AK-style pistol, and additional ammunition. On his phone, they also discovered texts relating to the selling of drugs.

At the sentencing, Kinney may receive a life sentence for the distribution of a controlled substance that caused death, up to 20 years for the other drug offenses, and up to 10 years for the firearms offense.

The Drug Enforcement Administration and the Florissant Police Department are still looking into this situation. 

 
Avatar photo

David Brown

With years of expertise in the field, i am bring a wealth of knowledge and insights to our platform. Our editor’s extensive research and understanding of the drug landscape ensure that their content is accurate, informative, and engaging.